financetom
Business
financetom
/
Business
/
Icahn Enterprises Prevails in Class Action Lawsuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Icahn Enterprises Prevails in Class Action Lawsuit
Sep 16, 2024 12:36 PM

08:53 AM EDT, 09/16/2024 (MT Newswires) -- Icahn Enterprises ( IEP ) said Monday that a proposed class action lawsuit against the company and certain directors and officers was dismissed without prejudice on Friday.

US District Court Judge K. Michael Moore ruled that the lawsuit, which was based on claims from Hindenburg Research, failed to prove "material misrepresentations or omissions" with an intent to fraud, Icahn Enterprises ( IEP ) said.

Icahn Enterprises ( IEP ) shares rose 1.7% in recent premarket activity.

Price: 10.98, Change: +0.18, Percent Change: +1.67

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Primo Water Reports Higher Q2 Adjusted Profit as Revenue Rises
Primo Water Reports Higher Q2 Adjusted Profit as Revenue Rises
Aug 8, 2024
07:09 AM EDT, 08/08/2024 (MT Newswires) -- Primo Water ( PRMW ) on Thursday reported higher adjusted profit and revenue for its second quarter. The company, which last month said it is merging with BlueTriton Brands, said adjusted net income rose to US$42 million, or US$0.26 per share, from US$31 million, or US$0.20 per share, last year. Revenue increased 7.6%...
Elanco Animal Health's Q2 Adjusted Earnings, Revenue Rise; Issues Q3 Guidance, Lowers FY Revenue Guidance
Elanco Animal Health's Q2 Adjusted Earnings, Revenue Rise; Issues Q3 Guidance, Lowers FY Revenue Guidance
Aug 8, 2024
07:05 AM EDT, 08/08/2024 (MT Newswires) -- Elanco Animal Health ( ELAN ) reported Q2 adjusted earnings Thursday of $0.30 per diluted share, up from $0.18 a year earlier. Analysts polled by Capital IQ expected $0.24. Revenue for the quarter ended June 30 was $1.18 billion compared with $1.06 billion a year earlier. Analysts polled by Capital IQ expected $1.15...
UK's antitrust regulator to probe Amazon's AI partnership with Anthropic
UK's antitrust regulator to probe Amazon's AI partnership with Anthropic
Aug 8, 2024
Aug 8 (Reuters) - Britain's competition watchdog said on Thursday it has initiated a probe into Amazon's ( AMZN ) AI partnership with Anthropic, days after it launched a similar enquiry into Alphabet's partnership with the startup. ...
US FDA approves Citius' blood cancer therapy
US FDA approves Citius' blood cancer therapy
Aug 8, 2024
Aug 6 (Reuters) - The U.S. Food and Drug Administration has approved Citius Pharmaceuticals' ( CTXR ) blood cancer therapy, Lymphir, for relapsed patients who have received at least one prior treatment, the company said on Thursday. The approval comes after the health regulator initially declined to approve the therapy last year, seeking additional product testing data. Lymphir, Citius' first...
Copyright 2023-2026 - www.financetom.com All Rights Reserved